Some anxiety medications are controlled substances and some are not. The answer depends entirely on which medication you’re taking or being prescribed. Benzodiazepines, the most widely recognized class of anxiety drugs, are federally controlled. But several other effective anxiety medications carry no controlled substance designation at all.
Benzodiazepines: Schedule IV Controlled
Benzodiazepines are classified as Schedule IV controlled substances under the federal Controlled Substances Act. This category includes familiar names like alprazolam (Xanax), lorazepam (Ativan), clonazepam (Klonopin), and diazepam (Valium). Schedule IV means the DEA considers them to have a legitimate medical use but also a real potential for misuse and dependence, though lower than drugs in Schedules I through III.
The reason for this classification is pharmacological. Benzodiazepines work by amplifying the effect of a calming brain chemical called GABA, which produces sedation, muscle relaxation, and anxiety relief. That same mechanism makes them feel rewarding to some people, creating a risk of misuse. With regular use over weeks or months, the body adapts to their presence. Stopping abruptly can trigger withdrawal symptoms ranging from rebound anxiety and insomnia to, in severe cases, seizures. This physical dependence is distinct from addiction (compulsive drug-seeking behavior), but it’s one of the main reasons these drugs are tightly regulated.
Anxiety Medications That Are Not Controlled
Several widely prescribed anxiety treatments have no controlled substance classification at all. The most important ones to know about:
SSRIs and SNRIs (such as sertraline, escitalopram, venlafaxine, and duloxetine) are first-line treatments for generalized anxiety disorder, social anxiety, and panic disorder. They work by adjusting serotonin or norepinephrine levels in the brain. They don’t produce a high, don’t cause the kind of physical dependence that benzodiazepines do, and have no abuse potential. They take several weeks to reach full effect, which is one reason they’re not misused recreationally.
Buspirone is specifically approved for anxiety and is not a controlled substance. Its FDA label states plainly that it shows no potential for abuse or diversion, and there’s no evidence it causes tolerance or physical or psychological dependence. In clinical studies, volunteers with a history of recreational drug use couldn’t distinguish buspirone from a placebo, while they clearly preferred benzodiazepines. Buspirone works through serotonin receptors rather than the GABA system, so it doesn’t produce sedation or muscle relaxation and won’t substitute for a benzodiazepine if you’re already dependent on one.
Hydroxyzine, an antihistamine sometimes prescribed for short-term anxiety relief, is also not a controlled substance. Neither are beta-blockers like propranolol, which are occasionally used to manage the physical symptoms of performance anxiety (racing heart, trembling hands).
Pregabalin and Gabapentin: A Gray Area
Pregabalin (Lyrica), used in some countries for generalized anxiety disorder, is a Schedule V controlled substance at the federal level. Schedule V is the lowest tier of control, indicating limited abuse potential compared to Schedule IV drugs like benzodiazepines. Pregabalin is not FDA-approved for anxiety in the United States, though it is prescribed for nerve pain and seizures.
Gabapentin is more complicated. It is not federally scheduled, but a growing number of states have independently classified it as a Schedule V controlled substance due to concerns about misuse, overdose risk, and deaths when combined with opioids. Kentucky, Tennessee, and West Virginia were the first to do so in 2017 and 2018. North Dakota, Michigan, and Virginia followed. If you’re prescribed gabapentin for anxiety-related symptoms, your state’s laws determine whether it’s treated as a controlled substance at the pharmacy.
What Controlled Status Means for Your Prescription
If your anxiety medication is a Schedule IV controlled substance (most commonly a benzodiazepine), federal law imposes specific limits on how it’s prescribed and refilled. A prescription cannot be filled or refilled more than six months after the date it was written. Within that six-month window, you’re limited to a maximum of five refills. After that, your prescriber must issue a new prescription.
In practice, this means more frequent contact with your doctor or prescriber than you’d need for an uncontrolled medication like an SSRI, which can often be prescribed with a year’s worth of refills. Some states impose additional requirements on top of the federal rules, such as mandatory use of prescription drug monitoring programs that track controlled substance fills across pharmacies. You may also find that controlled substance prescriptions can’t be transferred between pharmacies as easily, or that early refills are flagged automatically.
For non-controlled anxiety medications, none of these restrictions apply. Your doctor can write refills for a longer period, pharmacies can transfer prescriptions freely, and there’s no monitoring database involved.
Physical Dependence vs. Addiction
One reason this topic causes confusion is that people often conflate “controlled substance” with “addictive,” and “not controlled” with “safe to stop anytime.” Neither is quite right. Physical dependence means your body has adapted to a drug and will react when you stop it. This happens reliably with benzodiazepines used daily for more than a few weeks, and it can also happen with SSRIs, which cause well-documented discontinuation symptoms (dizziness, irritability, “brain zaps”) if stopped abruptly, despite not being controlled substances.
Addiction, on the other hand, involves compulsive use despite harmful consequences. Most people who take a benzodiazepine as prescribed do not develop addiction, even though they may become physically dependent. The controlled substance classification reflects the fact that these drugs have a meaningful risk of misuse in the broader population, not that every patient who takes them will develop a problem.
If you’re weighing options with your prescriber, the controlled status of a medication is one useful data point. It tells you something about the drug’s abuse potential, the regulatory hoops you’ll navigate at the pharmacy, and the level of monitoring your prescriber will maintain. But it doesn’t tell you everything about safety, side effects, or whether the medication is right for your situation.